PAIN MANAGEMENT

U.S. health advisers sharply criticized an experimental arthritis drug Thursday, saying that it was too risky, even with limits on its use.

The Food and Drug Administration issued a warning to two companies selling over-the-counter products labeled as containing cannabidiol (CBD) without receiving the agency’s approval to do so.

A panel on 'America's Newsroom' discusses the Biden administration decision to roll back a Trump administration measure for treating opioid addiction in the United States.

The Food and Drug Administration (FDA) on Thursday warned that early results from a safety trial on Pfizer’s arthritis and colitis drug, tofacitinib, revealed an increased risk of heart issues and cancer when compared to another medicine.

Multiple brands of the over-the-counter headache medication Excerdrin are facing a recall after many bottles were found to have holes in the bottom, prompting child poisoning concerns. 

The virus that causes COVID-19 acts as a pain reliever, suggests the findings of a new study that could offer “one possible explanation for the unrelenting spread” of the disease, researchers said. 

In the clinical trial patients are given a combination of baricitinib and remdesivir.

Just in time for Halloween, a new case report detailed the harrowing reason for an Australian woman’s persistent headache: tapeworm larvae. 

Face masks worn during the coronavirus pandemic have created a shift in demands in plastic surgery practices, one plastic surgeon said. 

Turmeric may help reduce pain in arthritic knees, according to a new study from the University of Tasmania’s Menzies Institute for Medical Research.